BERTOPEDICS
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €370,000. Estimated: probably between €210,000 and €630,000.
Balance sheet
balance sheet total €136,792 on 31-12-2025in euro
in euro
Position in the sector
49.2%
Higher than 64% of 25,388 companies in 2025.
1.91
Higher than 62% of 24,385 companies in 2025.
11.4%
Higher than 73% of 24,575 companies in 2025.
Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Balance sheet: assets | ||||
20/58 |
136,792 | 142,171 | 137,106 | |
21/28 |
32,023 | 44,572 | 53,418 | |
22/27 |
32,023 | 44,572 | 53,418 | |
23 |
3,092 | 3,912 | - | |
24 |
28,931 | 40,660 | 53,418 | |
29/58 |
104,769 | 97,599 | 83,689 | |
29 |
33,359 | 7,058 | 1,001 | |
291 |
33,359 | 7,058 | 1,001 | |
40/41 |
15,493 | 25,145 | 997 | |
40 |
15,493 | 12,320 | 0 | |
41 |
0 | 12,824 | 997 | |
54/58 |
55,257 | 63,492 | 79,365 | |
490/1 |
659 | 1,904 | 2,326 | |
| Balance sheet: equity and liabilities | ||||
10/49 |
136,792 | 142,171 | 137,106 | |
10/15 |
67,311 | 89,638 | 70,922 | |
10/11 |
1,000 | 1,000 | 1,000 | |
13 |
66,311 | 50,715 | 31,999 | |
130/1 |
- | - | 0 | |
1311 |
- | - | 0 | |
133 |
66,311 | 50,715 | 31,999 | |
14 |
0 | 37,923 | 37,923 | |
17/49 |
69,480 | 52,532 | 66,184 | |
17 |
14,750 | 23,963 | 32,708 | |
170/4 |
14,750 | 23,963 | 32,708 | |
42/48 |
54,730 | 28,570 | 32,591 | |
42 |
9,212 | 8,745 | 9,426 | |
44 |
5,425 | 6,438 | 3,343 | |
440/4 |
5,425 | 6,438 | 3,343 | |
45 |
9,943 | 13,387 | 19,822 | |
450/3 |
9,943 | 13,387 | 19,822 | |
47/48 |
30,150 | - | 0 | |
492/3 |
- | 0 | 886 | |
| Income statement | ||||
76A |
- | - | 8,693 | |
9900 |
41,578 | 44,565 | 44,647 | |
62 |
1,779 | - | - | |
630 |
12,549 | 12,946 | 8,313 | |
640/8 |
1,447 | 886 | 1,889 | |
9901 |
25,804 | 30,733 | 34,446 | |
75/76B |
316 | 360 | 50 | |
75 |
316 | 360 | 50 | |
65/66B |
1,638 | 2,018 | 1,367 | |
65 |
1,638 | 2,018 | 1,367 | |
9903 |
24,481 | 29,075 | 33,129 | |
67/77 |
8,885 | 10,359 | 14,744 | |
9904 |
15,596 | 18,716 | 18,386 | |
9905 |
15,596 | 18,716 | 18,386 | |
| Appropriation of the result | ||||
9906 |
15,596 | 56,639 | 56,309 | |
14P |
0 | 37,923 | 37,923 | |
691/2 |
15,596 | 18,716 | 18,386 | |
6921 |
15,596 | 18,716 | 18,386 | |
| Document | ||||
The notes to these accounts have 6 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 10-07-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankSubsidies and aid
Flemish government 2025, 1 entry, €150 awarded, €150 paid
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| 38,353 | 43,679 | 42,758 | ||
| 28,145 | 31,662 | 26,698 | ||
| 0 | 4,100 | 58,645 | ||
| -8,235 | -15,873 | - | ||
| 50,038 | 69,029 | 51,098 | ||
| 49.2% | 63.0% | 51.7% | ||
| 1.91 | 3.42 | 2.57 | ||
| 1.03 | 0.59 | 0.93 | ||
| 23.2% | 20.9% | 25.9% | ||
| 11.4% | 13.2% | 13.4% | ||
| 23.41 | 21.65 | 31.29 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Tangible fixed assets | - | €4,100 | €58,645 |
| €12,549 | €12,946 | €8,313 |
Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)
Insights on BERTOPEDICS
The operating result for 2025 is 16% lower than in 2024 and the lowest since 2023. It is the second fall in a row.
Debt's share of the balance-sheet total rises from 37.0% to 50.8%. Equity is lower and debt is higher.